More on AQST

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+14.3% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (11/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Aquestive Therapeutics Inc. (NQ:AQST)
Delayed: 4.00 -0.13 (3.15%)
Prev. Close $4.13  
Open$4.08 
52 Wk High$ 
52 Wk Low$ 
Day High$4.14 
Day Low$3.97 
P/E N/A  
EPS$ 
Volume1,746,679 

Friends, Peers and Foes (?): TLSA (more...)

Oct 23, 2026 01:39 PM Form 4 Aquestive Therapeutics, For: Oct 21 Filed by: Cochran John
Oct 19, 2026 04:05 PM Form 8-K Aquestive Therapeutics, For: Oct 15
Oct 16, 2026 02:17 PM Form 4 Aquestive Therapeutics, For: Oct 15 Filed by: Barber Daniel
Oct 16, 2026 01:58 PM Form 3 Aquestive Therapeutics, For: Oct 15 Filed by: Daly Richard J
Oct 16, 2026 08:07 AM H.C. Wainwright Reiterates Buy Rating on Aquestive Therapeutics (AQST)
Oct 15, 2026 07:21 AM Form 8-K Aquestive Therapeutics, For: Oct 15
Oct 15, 2026 07:00 AM FDA accepts Aquestive's Anaphylm NDA resubmission with March 2027 review date
Oct 15, 2026 07:00 AM Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027
Oct 14, 2026 07:21 AM Form 8-K Aquestive Therapeutics, For: Oct 13
Oct 14, 2026 06:51 AM Eton and Aquestive strike U.S. deal for diazepam buccal film
View All Articles

Entities mentioned with AQST

View All Entities